Related Experiment Video

Updated: Jan 14, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.4K

[Pharmaceutical Professional Services for Metabolic Syndrome. Methodology and Analysis: A Pilot Study]

Jaq Benítez Perdomo1, S Gutierrez Moreno2, A Roman Murillo1

  • 1Técnico en Farmacia España.

Farmaceuticos Comunitarios
|October 22, 2025
PubMed
Summary

Community Pharmacy Services (CPS) for Metabolic Syndrome (MS) monitoring in community pharmacies (CP) improve patient loyalty and economic outcomes. Early detection of MS through CPS benefits both patients and pharmacy businesses.

Keywords:
Community Pharmacy ServicesEconomic IndexesHealth Status IndicatorsMetabolic SyndromeProfessional Pharmaceutical Care Services

More Related Videos

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults14:39

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

4.3K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.7K

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165